US 7229986
Melanin-concentrating hormone antagonist
granted A61KA61K31/404A61K31/454
Quick answer
US patent 7229986 (Melanin-concentrating hormone antagonist) held by Takeda Pharmaceutical Company Limited expires Mon Jun 07 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jun 12 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 07 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/404, A61K31/454, A61K31/4709, A61K31/4725